Accuray | ARAY - Operating Expenses


Accuray reported $37.18M in Operating Expenses for its fiscal quarter ending in December of 2024.





Operating Expenses Change Date
Abbott USD 11.66B 1.2B Sep/2026
Accuray USD 37.18M 567K Dec/2024
AngioDynamics USD 81.95M 1.68M Sep/2025
Artivion USD 111.2M 9.45M Dec/2025
AtriCure USD 143.94M 3.22M Jun/2026
Boston Scientific USD 4.2B 49M Jun/2026
Edwards Lifesciences USD 1.22B 87.6M Jun/2026
Inogen USD 49.14M 665K Sep/2024
Mesa Laboratories USD 33.98M 2.03M Dec/2024
Orthofix International USD 213.79M 12.36M Dec/2025
Tandem Diabetes Care USD 268.35M 3.7M Jun/2026
Trinity Biotech USD 12.38M 2.44M Dec/2025